MAVS ANTIBODY Usage And Synthesis

Source

Rabbit

Reactivity

Mouse;Rat

Background

The mitochondrial antiviral signaling protein contributes to innate immunity by triggering IRF-3 and NF-κB activation in response to viral infection, leading to the production of IFN-β. The MAVS protein contains an N-terminal CARD domain and a C-terminal mitochondrial transmembrane domain. The MAVS adaptor protein plays a critical and specific role in viral defenses. MAVS acts downstream of the RIG-I RNA helicase and viral RNA sensor, leading to the recruitment of IKKε, TRIF, and TRAF6. Some viruses have evolved strategies to circumvent these innate defenses by using proteases that cleave MAVS to prevent its mitochondrial localization.

References

[1] Seth, R.B. et al. (2005) Cell 122, 669-682.
[2] Sun, Q. et al. (2006) Immunity 24, 633-642.
[3] Xu, L.G. et al. (2005) Mol. Cell 19, 727-740.
[4] Yoneyama, M. et al. (2004) Nat. Immunol. 5, 730-737.
[5] Lin, R. et al. (2006) J. Virol. 80, 6072-6083.
[6] Chen, Z. et al. (2007) J. Virol. 81, 964-976.

MAVS ANTIBODY()Related Product Information

• GPR65 antibody
• FABP1 antibody
• SRGAP2 antibody
• RNF5 antibody
• STARD4 Antibody
• NR2F2 antibody
• ELOVL6 antibody
• LIMK1 antibody
• TBC1D4 antibody
• GABRG2 Antibody